Literature DB >> 19001468

Intra-articular injection composed of steroid, iohexol and local anaesthetic: is it stable?

K Shah1, D Watson, C Campbell, R M D Meek.   

Abstract

The aim of this study is to determine the chemical stability of a suspension of steroid, radiographic contrast material and local anaesthetic. Image-guided steroid injection using a contrast material is widely used for several musculoskeletal conditions. Manufacturers of these agents do not advise mixture in a single syringe, as the chemical stability is unknown. They suggest that, if required, these agents should be injected separately. However, the agents will be mixed together when injected into a contained space within the body. It would seem unethical to continue this in clinical practice until the stability of such a mixture is established. High-performance liquid chromatographic (HPLC) analysis was used to assess the stability of combinations of steroids (triamcinolone and methylprednisolone) and Omnipaque (iohexol). Further analysis was also performed to test the stability of adding local anaesthetics (lidocaine and bupivacaine) to these mixtures. The results demonstrated that all combinations were stable when mixed together. In conclusion, these results support the continued safe use of these products in combination in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001468     DOI: 10.1259/bjr/47132569

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  2 in total

1.  Cytotoxicity of local anesthetics and nonionic contrast agents on bovine intervertebral disc cells cultured in a three-dimensional culture system.

Authors:  Ana V Chee; Jing Ren; Brett A Lenart; Er-Yun Chen; Yejia Zhang; Howard S An
Journal:  Spine J       Date:  2013-11-15       Impact factor: 4.166

2.  Physical and Chemical Compatibility of Extended-Release Triamcinolone Acetonide (TA-ER) with Common Local Anesthetics.

Authors:  J Derek Jackson; Lindsey Cotton; Melinda Turkington; Daniel Leblanc; Scott Kelley
Journal:  Adv Ther       Date:  2019-01-31       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.